(R)-N-(2-Hydroxy-2-methyl-1-phenylpropyl)-4-methylbenzenesulfonamide

Catalog No. :
ACZPYV840
CAS No. :
620627-46-5
Molecular Formula :
C17H21NO3S
Molecular Weight :
319.43

IUPAC Name:(R)-N-(2-hydroxy-2-methyl-1-phenylpropyl)-4-methylbenzenesulfonamide

(R)-N-(2-Hydroxy-2-methyl-1-phenylpropyl)-4-methylbenzenesulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$98.00Login to see priceInquiryInquiry
1g97%$204.00Login to see priceInquiryInquiry
5g97%$788.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-N-(2-Hydroxy-2-methyl-1-phenylpropyl)-4-methylbenzenesulfonamide
IUPAC Name(R)-N-(2-hydroxy-2-methyl-1-phenylpropyl)-4-methylbenzenesulfonamide
MDL No.MFCD09025333
Molecular FormulaC17H21NO3S
Molecular Weight319.43
SMILESO=S(C1=CC=C(C)C=C1)(N[C@H](C2=CC=CC=C2)C(C)(O)C)=O
InChI KeyZTVQXNICBNVQJO-MRXNPFEDSA-N
SynonymN-(2-hydroxy-2-methyl-1-phenylpropyl)-4-methylbenzenesulfonamide;(R)-N-(2-Hydroxy-2-methyl-1-phenyl-propyl)-4-methyl-benzenesulfomide;Benzenesulfonamide, N-[(1R)-2-hydroxy-2-methyl-1-phenylpropyl]-4-methyl-
CAS No.620627-46-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACZPYV840 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZPYV840 route product structure diagram
    ACZPYV840620627-46-5
Inquiry

2. ACZPYV840 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZPYV840 route product structure diagram
    ACZPYV840620627-46-5
Inquiry

Comments (0)